Pfizer reshuffles top leadership to hone commercial strategy, leaving room for new rare disease chief
Some shuffling is taking place at the top ranks of Pfizer.
Longtime exec Andy Schmeltz announced on LinkedIn that he’s moving onto his next tour …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
